208 related articles for article (PubMed ID: 28517963)
1. Novel strategies in vaccine design: can nanocapsules help prevent and treat hepatitis B?
Gehring S; Pietrzak-Nguyen A; Fichter M; Landfester K
Nanomedicine (Lond); 2017 Jun; 12(11):1205-1207. PubMed ID: 28517963
[No Abstract] [Full Text] [Related]
2. Do we need better hepatitis B vaccines?
Gerlich WH
Indian J Med Res; 2017 Apr; 145(4):414-419. PubMed ID: 28862172
[No Abstract] [Full Text] [Related]
3. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
[TBL] [Abstract][Full Text] [Related]
4. [Persistence of immunity after hepatitis B vaccination].
Madaliński K
Przegl Epidemiol; 2002; 56(4):605-13. PubMed ID: 12666586
[TBL] [Abstract][Full Text] [Related]
5. Development of Adjuvanted Solid Fat Nanoemulsions for Pulmonary Hepatitis B Vaccination.
Minz S; Pandey RS
J Pharm Sci; 2018 Jun; 107(6):1701-1712. PubMed ID: 29454622
[TBL] [Abstract][Full Text] [Related]
6. [Hepatitis B vaccine].
Kurokohchi K; Kuriyama S
Nihon Rinsho; 2005 May; 63 Suppl 5():638-42. PubMed ID: 15954422
[No Abstract] [Full Text] [Related]
7. [The impact of hepatitis B vaccination in Italy and the advent of novel recombinant vaccines containing pre-S1 and pre-S2].
Romanò L; Biffi R; Bianchi S; Zanetti A
Ann Ig; 2002; 14(3 Suppl 3):19-25. PubMed ID: 12389407
[No Abstract] [Full Text] [Related]
8. A boost to hepatitis B vaccine: no need for boosters.
Aggarwal R
Natl Med J India; 2005; 18(6):313-4. PubMed ID: 16483032
[No Abstract] [Full Text] [Related]
9. A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen.
Simons BC; Spradling PR; Bruden DJ; Zanis C; Case S; Choromanski TL; Apodaca M; Brogdon HD; Dwyer G; Snowball M; Negus S; Bruce MG; Morishima C; Knall C; McMahon BJ
J Infect Dis; 2016 Jul; 214(2):273-80. PubMed ID: 27056956
[TBL] [Abstract][Full Text] [Related]
10. [Hepatitis B vaccine in patients with human immunodeficiency virus infection].
Ramírez O CA; Fernández A DG; Valderrama B SL; Gómez Q CH; Támara R JR; Alvarez M CA
Rev Chilena Infectol; 2009 Feb; 26(1):26-33. PubMed ID: 19350156
[TBL] [Abstract][Full Text] [Related]
11. Development of an Allergy Immunotherapy Leads to a New Type of Hepatitis B Vaccine.
Gerlich WH; Glebe D
EBioMedicine; 2016 Sep; 11():5-6. PubMed ID: 27485030
[No Abstract] [Full Text] [Related]
12. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.
Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z
Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398
[TBL] [Abstract][Full Text] [Related]
13. DNA vaccines for prophylactic or therapeutic immunization against hepatitis B.
Michel ML; Loirat D
Intervirology; 2001; 44(2-3):78-87. PubMed ID: 11509869
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of hepatitis B virus infection in middle school students born after the universal infant vaccination program in Shanghai, China.
Wang WL; Shu ZJ; Zhou LX; Zhao YR
Arch Virol; 2012 May; 157(5):901-5. PubMed ID: 22327392
[TBL] [Abstract][Full Text] [Related]
15. Persistent and transient hepatitis B virus (HBV) infections in children born to HBV-infected mothers despite active and passive vaccination.
Boot HJ; Hahné S; Cremer J; Wong A; Boland G; van Loon AM
J Viral Hepat; 2010 Dec; 17(12):872-8. PubMed ID: 20051008
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years.
Gilbert CL; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK
Hum Vaccin; 2011 Dec; 7(12):1336-42. PubMed ID: 22185811
[TBL] [Abstract][Full Text] [Related]
17. Influence of circadian rhythm on the efficacy of the hepatitis B vaccination.
Karabay O; Temel A; Koker AG; Tokel M; Ceyhan M; Kocoglu E
Vaccine; 2008 Feb; 26(9):1143-4. PubMed ID: 18255201
[No Abstract] [Full Text] [Related]
18. Efficacy and long-term durability of intradermal recombinant hepatitis B virus vaccine among intramuscular vaccine nonresponders: A prospective study in healthcare personnel.
Kalchiem-Dekel O; Grupel D; Bouchnik L; Sikuler E; Ben-Yakov G
J Gastroenterol Hepatol; 2015 Dec; 30(12):1782-7. PubMed ID: 26101816
[TBL] [Abstract][Full Text] [Related]
19. Immunoprophylaxis failure against vertical transmission of hepatitis B virus: what is the mechanism and do other factors also play a role?
Shin JI; Namgung R; Park MS; Park KI; Lee C
Eur J Pediatr; 2008 Apr; 167(4):489-90. PubMed ID: 17516085
[No Abstract] [Full Text] [Related]
20. A randomized clinical trial of immunization with combined hepatitis A and B versus hepatitis B alone for hepatitis B seroprotection in hemodialysis patients.
Tung J; Carlisle E; Smieja M; Kim PT; Lee CH
Am J Kidney Dis; 2010 Oct; 56(4):713-9. PubMed ID: 20630640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
